- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06505694
A Clinical Trial to Assess the Impact of an Alcohol Alternative Herbal Tincture on Signs of Stress Anxiety and Sleep Quality.
April 22, 2025 updated by: Apothekary
This is a virtual randomized placebo-controlled double-blind trial lasting eight weeks.
The trial will assess the effects of a test product on improving sleep quality, promoting a sense of calm, and reducing feelings of stress and anxiety, using a sleep tracker and subject-specific questionnaires.
The study involves 80 participants who experience sleep issues and feelings associated with stress and anxiety.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Santa Monica, California, United States, 90404
- Citruslabs
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Aged 21-65 years
- Male or female
- Good general health
- Experience daily feelings of stress and anxiety within the past two weeks
- Experience daily problems with sleeping, reduced energy levels, and fatigue over the past two weeks
- Have used alcohol products to help relax or sleep within the past two weeks
- Experience tension in the body within the past two weeks
- Experience problems with relaxing in the evening within the past two weeks
- Willing to abstain from alcohol for the duration of the study
- Willing to maintain stable use of other herbal supplements, over-the-counter medications, or prescriptions during the study
Exclusion Criteria:
- Chronic health conditions, including oncological and psychiatric disorders
- Taking SSRIs, sedative, or blood pressure-lowering medications
- Pregnant, breastfeeding, or planning to conceive within the next three months
- Currently enrolled or planning to enroll in another research trial over the next eight weeks
- History of substance abuse
- Known serious allergic reactions requiring an Epi-Pen
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Test Product Arm
Participants in this arm will receive the test product, which is an alcohol alternative herbal tincture.
The intervention includes taking 2 ml of the test product directly onto the tongue every evening, 1-2 hours before bedtime, for a duration of 8 weeks.
|
The test product contains organic vegetable glycerin, distilled water, organic elderberries, organic bilberries, organic beetroot juice powder, organic California poppy (whole plant), organic tart cherry, organic hawthorn berries, organic blue vervain (aerial parts), organic ceylon cinnamon bark, organic black pepper fruit, and L-theanine.
|
|
Placebo Comparator: Placebo Arm
Participants in this arm will receive a placebo.
The intervention includes taking 2 ml of the placebo directly onto the tongue every evening, 1-2 hours before bedtime, for a duration of 8 weeks.
|
The placebo is designed to match the test product in appearance and taste but does not contain the active herbal ingredients.
Participants will take 2 ml of the placebo directly onto the tongue every evening, 1-2 hours before bedtime, for a duration of 8 weeks.
The placebo contains organic vegetable glycerin, distilled water, organic beet juice powder, organic tart cherries, organic ceylon cinnamon chips, and natural green food coloring (derived from spirulina and turmeric).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improvements in Sleep Quality and Mental Well-Being
Time Frame: Baseline, Week 2, Week 4, Week 6, and Week 8
|
Changes in sleep quality, mental well-being, stress, and feelings of anxiety will be assessed using self-assessment questionnaires.
Participants will complete these questionnaires at specified intervals throughout the study to evaluate the effectiveness of the herbal tincture compared to the placebo.
|
Baseline, Week 2, Week 4, Week 6, and Week 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Sleep Length and Quality
Time Frame: Baseline, Week 4, and Week 8
|
Changes in sleep length and quality will be monitored using a Fitbit sleep tracker.
The sleep tracker will collect data on various sleep parameters, including total sleep time and sleep stages, to assess the impact of the herbal tincture compared to the placebo.
|
Baseline, Week 4, and Week 8
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 9, 2024
Primary Completion (Actual)
August 20, 2024
Study Completion (Actual)
August 20, 2024
Study Registration Dates
First Submitted
July 11, 2024
First Submitted That Met QC Criteria
July 11, 2024
First Posted (Actual)
July 17, 2024
Study Record Updates
Last Update Posted (Actual)
April 24, 2025
Last Update Submitted That Met QC Criteria
April 22, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20381
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Center for Advanced Facial Plastic SurgeryCompletedStress | Stress, Physiological | Stress Response | Stress (Psychology) | Healthy Adult Female Participants | Stress, Psychologic | Stress Perception | Stress Levels | Stress, Psychological CumulativeUnited States
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...CompletedStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Amasya UniversityCompletedThe Effect of Online Stress Management Program on Nurses' Individual Workload Perception, and StressStress | Nursing | Stress ManagementTurkey (Türkiye)
-
Canterbury Christ Church UniversitySussex Partnership NHS Foundation TrustEnrolling by invitationOccupational Stress or Workplace StressUnited Kingdom
-
University of PadovaCompletedStress | Stress Disorder | Work Related StressItaly
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
Dana-Farber Cancer InstituteCompletedStress | Post Traumatic Stress Disorder | Work Related StressUnited States
-
University of North Carolina, Chapel HillWashington University School of Medicine; United States Department of Defense; University of Florida and other collaboratorsRecruitingPost-traumatic Stress Disorder | Acute Stress Disorder | Acute Stress ReactionUnited States
Clinical Trials on Alcohol Alternative Herbal Tincture (Test Product)
-
Burzynski Research InstituteWithdrawnStage IV Colon Cancer | Recurrent Colon Cancer | Adenocarcinoma of the ColonUnited States
-
Lund UniversityCompletedGlucose Tolerance | Appetite SensationsSweden
-
COD Research Private LtdCompletedFatty Liver Without Mention of AlcoholIndia
-
Queen Mary University of LondonGlaxoSmithKlineCompletedCovid19 | CoronavirusUnited Kingdom
-
Eva CubricClinical Hospital Merkur; University Hospital Rijeka; University Hospital Dubrava and other collaboratorsNot yet recruitingHypertension | Diabetes Mellitus | Hyperlipidaemia | MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Croatia
-
Mucosa Innovations, S.L.Universidad de GranadaCompleted
-
Gaia Herbs Inc.Nutrasource Pharmaceutical and Nutraceutical Services, Inc.Completed
-
Indiana UniversityHALEONCompleted